Valuation: Novonesis A/S

Capitalization 19TCr 2.96TCr 2.52TCr 2.34TCr 2.18TCr 4.07TCr 2,72300Cr 4.31TCr 27TCr 11TCr 1,28600Cr 11TCr 11TCr 4,67700Cr P/E ratio 2025 *
38.5x
P/E ratio 2026 * 33.2x
Enterprise value 21TCr 3.29TCr 2.8TCr 2.6TCr 2.43TCr 4.52TCr 3,02600Cr 4.79TCr 30TCr 12TCr 1,42900Cr 12TCr 12TCr 5,19600Cr EV / Sales 2025 *
6.68x
EV / Sales 2026 * 6.19x
Free-Float
73.7%
Yield 2025 *
1.49%
Yield 2026 * 1.66%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.70%
1 week-3.39%
Current month-0.91%
1 month-0.17%
3 months-0.96%
6 months-8.90%
Current year-0.91%
More quotes
1 week 400.4
Extreme 400.4
414.7
1 month 395.3
Extreme 395.3
425.3
Current year 395.3
Extreme 395.3
425.3
1 year 368.5
Extreme 368.5
489.4
3 years 274.6
Extreme 274.6
489.4
5 years 274.6
Extreme 274.6
545.8
10 years 220.7
Extreme 220.7
545.8
More quotes
Change 5d. change 1-year change 3-years change Capi.($)
-1.70%-3.39%-0.91%+14.09% 3.01TCr
+3.03%+3.71%+34.10%-11.29% 586.65Cr
+0.31%-0.61%+3.03%+30.46% 198.47Cr
+2.05%+3.93%+20.26%-40.05% 72Cr
-0.27%+6.84%+16.69%-17.12% 60Cr
-.--%+22.59% - - 22Cr
-3.65%-7.66%-21.92%-40.67% 7.05Cr
+0.39%-0.77%-9.82%-6.88% 6.81Cr
Average +0.02%+2.35%+5.92%-10.21% 495.16Cr
Weighted average by Cap. -0.80%-1.31%+5.10%+9.54%
See all sector performances

Financials

2025 *2026 *
Net sales 3.13TCr 492.61Cr 418.96Cr 388.34Cr 362.9Cr 676.51Cr 45TCr 717.04Cr 4.44TCr 1.76TCr 21TCr 1.85TCr 1.81TCr 78TCr 3.34TCr 526.26Cr 447.58Cr 414.87Cr 387.68Cr 722.72Cr 48TCr 766.02Cr 4.74TCr 1.88TCr 23TCr 1.97TCr 1.93TCr 83TCr
Net income 473.85Cr 75Cr 63Cr 59Cr 55Cr 102.51Cr 6.86TCr 108.65Cr 672.48Cr 266.98Cr 3.24TCr 279.89Cr 274.16Cr 12TCr 564.97Cr 89Cr 76Cr 70Cr 66Cr 122.22Cr 8.18TCr 129.54Cr 801.8Cr 318.32Cr 3.86TCr 333.71Cr 326.88Cr 14TCr
Net Debt 2.09TCr 329.02Cr 279.83Cr 259.38Cr 242.38Cr 451.85Cr 30TCr 478.92Cr 2.96TCr 1.18TCr 14TCr 1.23TCr 1.21TCr 52TCr 1.88TCr 296.01Cr 251.76Cr 233.35Cr 218.07Cr 406.52Cr 27TCr 430.87Cr 2.67TCr 1.06TCr 13TCr 1.11TCr 1.09TCr 47TCr
More financial data * Estimated data
Logo Novonesis A/S
Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - agriculture, bioenergy and animal feed industries (36.5%); - food industries (32.3%); - cleaning and household care products industries (20%); - human nutritional health industries (11.2%). Net sales are geographically distributed as follows: Denmark (0.8%), Europe/Middle East/Africa (34.9%), North America (32.9%), Asia/Pacific (18.9%) and Latin America (12.5%).
Employees
10,582
More about the company
Date Price Change Volume
23/26/23 404.10 kr -1.70% 7,01,292
22/26/22 411.10 kr +0.83% 6,23,200
21/26/21 407.70 kr -0.20% 5,78,821
20/26/20 408.50 kr +0.67% 4,45,831
19/26/19 405.80 kr -2.99% 3,68,681

Delayed Quote Nasdaq Copenhagen, January 23, 2026 at 09:50 pm IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
404.10DKK
Average target price
467.96DKK
Spread / Average Target
+15.80%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. NSIS B Stock